Pharmacy-driven medication histories decreased length of stay and in-hospital mortality @AJHPOfficial @ASHPOfficial A monumental team effort and the first study to look at hard outcomes. With @PharmDirJM @jlkoehl @giulietti_Rx @DavidLucierMD, & others.

It’s embarrassing that in a specialty where pharmacists and physicians work side-by-side caring for patients at the beside, we continue to see disparaging of other professions. It’s disheartening because many have worked tirelessly to build collaboration and teamwork.

@psychunseen I haven’t looked at that. My focus in emergency medicine is generally acute agitation where we often use parental agents. The studies like to look at time points (15, 30, 60 minutes etc), so it’s difficult to determine actual onset times.

We have an ED pharmacist position open on our team at MGH in Boston! Apply here:

It still brings me great joy to watch pharmacology in action while on clinical shift in the ED. My 3 favorites are: naloxone, physostigmine (RIP), and high-dose nitroglycerin + BiPAP (for 'flash' pulmonary edema).

@reverendofdoubt What’s your management approach to these patients when they present to the ED: 1) on their own after a home BP reading, 2) on advice of the after-hours PCP coverage clinician, and/or 3) after they were checked in for a same-day procedure at your hospital?

I can now retire. Published in today's issue of @NEJM. @MassGeneralNews

What a multi-site collaborative effort to see this one through to completion! Free downloads here in @Clin_Tox: @PeterRchai @Harvard_Tox

@warejko I'm still hoping to understand someday why @aaeminfo included pharmacists in their 2020 statement. We don't perform procedures or detract from resident education (quite the opposite, in fact).

RT @acmtmedtox: >>lt;< New ACMT Position Statement: End Use of the Term "Excited Delirium" 🧵 @TonyPizon @louisekao44 @…

I’ve worked side by side with incredible EM doctors for 16 years. I can assure you this sentiment is not representative of the specialty. If you’d like to be educated on what an EM pharmacist is, here’s a thread from the pervious time…

Earning a blue check mark during the pandemic, as a pharmacist, meant a lot. Health care workers sharing real-world experience, educating, and interpreting evolving scientific data was critical. But, the platform and culture changed. Pay-to-play just isn’t what #FOAMed is about.

@vlad_sok @AcademicEmerMed @ALiEMteam We use 2-4 gm infused over 10-15 minutes.

@doctorsaluja @AcademicEmerMed @ALiEMteam We use it for most patients. 2-4 gm.

I spot at least two EM pharmacists on the new Fellow of ASHP (FASHP) induction list. Congrats @DEZ_EM_Pharm and @memusselman!

RT @nytimes: Breaking News: The FDA approved Narcan, a nasal spray that reverses opioid overdoses, for over-the-counter sales. https://t.co…

Xylazine is back in the headlines as an adulterant (. It acts similarly to other alpha-2 agonists (clonidine, guanfacine) and causes hypotension, bradycardia, lethargy, and miosis. Good review on poisonings by @DEZ_EM_Pharm et al.

Xylazine is in the headlines again with a new DEA alert (. With poisoning, we see effects as we would with other alpha-2 agonists (clonidine, guanfacine) such as hypotension, bradycardia, and lethargy (. cc: @DEZ_EM_Pharm

Added a bunch of new EM pharmacists to the list after the resident match this week. The growing family is up to 615. Let me know if I'm missing anyone (I go by what's listed in profiles). Follow the list if you want to see what EM pharmacists tweet about!